|
KLHL23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.58449997567089E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.52829970900825E-11 |
| Normal-vs-Stage2 |
5.820300E-04 |
| Normal-vs-Stage3 |
1.121660E-02 |
| Normal-vs-Stage4 |
1.364190E-01 |
| Stage1-vs-Stage2 |
5.657600E-01 |
| Stage1-vs-Stage3 |
2.460400E-02 |
| Stage1-vs-Stage4 |
3.489800E-01 |
| Stage2-vs-Stage3 |
2.167800E-01 |
| Stage2-vs-Stage4 |
4.939400E-01 |
| Stage3-vs-Stage4 |
8.489600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56399999617918E-08 |
| Normal-vs-AfricanAmerican |
2.98240000473626E-08 |
| Normal-vs-Asian |
1.735060E-03 |
| Caucasian-vs-AfricanAmerican |
6.688000E-01 |
| Caucasian-vs-Asian |
8.811400E-01 |
| AfricanAmerican-vs-Asian |
9.993800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.0035973708209E-12 |
| Normal-vs-Female |
1.166420E-04 |
| Male-vs-Female |
2.400400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.83829000000024E-05 |
| Normal-vs-Extreme_Weight |
1.83231207984136E-12 |
| Normal-vs-Obese |
4.52250000004817E-07 |
| Normal-vs-Extreme_Obese |
2.58200000002873E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.028400E-01 |
| Normal_Weight-vs-Obese |
9.412200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.623400E-01 |
| Extreme_Weight-vs-Obese |
3.344300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.354000E-01 |
| Obese-vs-Extreme_Obese |
2.836000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.757800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.5195000003263E-07 |
| Normal-vs-Age(61-80Yrs) |
4.65899985258034E-10 |
| Normal-vs-Age(81-100Yrs) |
1.03689999997325E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.932200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.032750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.179810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.237350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.418590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.218400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
1.188940E-04 |
| Normal-VS-KIRP CIMP |
2.618500E-02 |
| Normal-VS-Unclassified PRCC |
1.76680999999235E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.787900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.540600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.916200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.179600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.230000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.824600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.90509999950817E-07 |
| Normal-vs-N1 |
6.076000E-01 |
| Normal-vs-N2 |
9.951700E-02 |
| N0-vs-N1 |
6.838100E-03 |
| N0-vs-N2 |
4.764200E-01 |
| N1-vs-N2 |
4.642400E-01 |
|
|
